期刊文献+

经肝动脉灌注^(32)P-玻璃微球联合化疗栓塞治疗肝癌的临床研究 被引量:14

Clinical research of intra-arterial radioembolization with ^(32)P-glass microspheres combined with chemoembolization for treatment of liver cancer
原文传递
导出
摘要 目的探讨经肝动脉超选择性灌注32P-玻璃微球联合化疗栓塞治疗肝癌的方法、疗效、影响因素和吸收剂量估算方法。方法采用经肝动脉超选择性段性挤压式栓塞及半肝栓塞的方法灌注32P-玻璃微球、超液化碘油和吡柔比星(THP)混悬液治疗30例肝癌患者,术后行β轫致辐射显像,结合分区模型,估算肿瘤、非瘤肝组织和肺组织的吸收剂量。采用不含32P-玻璃微球的混悬液化疗栓塞治疗26例肝癌患者作为对照组。结果实验组反应率(70.0%)明显高于对照组(42.3%)(χ2=4.362,P<0.05);实验组6、12、18个月生存率分别为100.00%、76.67%、43.33%,对照组为92.31%、61.54%、19.23%。估算肿瘤组织的平均吸收剂量(130.34±54.53)Gy,非瘤肝组织为(34.73±13.41)Gy,肺组织2.1~16.3Gy。肿瘤吸收剂量≥120Gy的反应率(100%)高于剂量<120Gy的反应率(47.1%)(χ2=9.832,P<0.01)。结论经肝动脉采用超选择性段性挤压式栓塞及半肝栓塞的方法灌注32P-玻璃微球联合化疗栓塞治疗肝癌是1种安全有效的方法。术后β轫致辐射显像结合分区模型估算肿瘤组织和非瘤肝组织的吸收剂量,为剂量学研究提供了1个可行的方法。 Objective To study the therapy method, effect and radiation doses estimation in clinical research of intra-arterial radioembolization with ^32 P-glass microspheres combined with chemoembolization for treatment of liver cancer. Methods Thirty patients with liver cancer were treated by infusion of suspension of ^32 P-glass microspheres mixed with lipiodol-ultrafluid(5 -20 ml) and THP( 10 mg) via hepatic-artery with method of segmental and half-hepatic embolization. β bremsstrahung imaging was performed after treatment, combined with partition modal, radiation doses in tumor, normal liver tissue and lung tissue were estimated respectively. Twenty-six patients with liver cancer were treated by chemoembolization with lipiodol-ultrafluid in control group. Results The response rate of treatment group is 70.0%, higher than 42. 3% of control group ( P 〈 0. 05 ). The survival rate of 6, 12, 18 months was 100. 00%, 76. 67%, 43.33% in treatment group, and 92.31%, 61.54%, 19. 23% in control group respectively. The mean estimated radiation doses in tumors were ( 130. 34± 54. 53) Gy, (34. 73 ± 13.41 ) Gy in normal liver tissue, and ranged from 2. 1 to 16. 3 Gy in lung tissue. The rate of response was 100% in 13 patients who received radiation doses of 〉t 120 Gy to tumor, and 47.1% in 17 patients who received radiation doses of 〈 120 Gy to tumor (P 〈 0. 01 ). Conclusions Super selective intra-arterial radioembolization with ^32P-glass microspheres combined with chemoembolization is a effective and safe treatment of liver cancer. Estimation of radiation doses in tumor, normal liver tissue and lung tissue respectively with β bremsstrahung imaging and partition modal is a practical method for radiation dose research.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2005年第10期1068-1072,共5页 Chinese Journal of Radiology
基金 天津市自然科学基金资助项目(003607111)
关键词 肝细胞 磷放射性同位素 放射学 介入性 栓塞 治疗性 ^32P-玻璃微球 化疗栓塞治疗 经肝动脉灌注 肝癌患者 临床研究 联合 Carcinoma, hepatocellular Phosphorus radioisotopas Radiology, interventional Embolization, therapeutic
  • 相关文献

参考文献12

  • 1Nijsen F, Rook D, Brandt C, et al. Targeting of liver tumour in rats by selective delivery of holmium-166 loaded microspheres: a biodistribution study. Eur J Nucl Med, 2001, 28:743-749.
  • 2Campbell AM, Bailey IH, Burton MA. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol, 2000,45: 1023-1033.
  • 3Campbell AM, Bailey IH, Burton MA. Tumour dosimetry in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol, 2001, 46:487-498.
  • 4秦明秀 刁国平 等.临床介入核医学[M].天津:天津科学技术出版社,1996.209-241.
  • 5Ho S, Lau WY, Leung TW, et al. Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours. Eur J Nucl Med, 1996, 23: 947-952.
  • 6郭金和,滕皋军,何仕诚,方文.^(32)P-玻璃微球肝动脉栓塞对肝组织损伤的实验评估[J].中华放射学杂志,1999,33(10):667-671. 被引量:1
  • 7Vokes EE, Weichselbaum RR. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors(Review). J Clin Oncol, 1990,8:911-934.
  • 8Chenoufi N, Raoul JL, Lescoat G, et al. In vitro demonstration of synergy between radionuclide and chemotherapy. J Nucl Med, 1998,39:900-903.
  • 9Andrews JC, Walker SC, Ackermann RJ, et al. Hepatic Radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med, 1994, 35: 1637-1644.
  • 10Shepherd FA, Rotstein LE, Houle S, et al. A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinoma. Cancer, 1992, 70:2250-2254.

二级参考文献12

共引文献10

同被引文献147

引证文献14

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部